The bioactive dressing materials may have intrinsic wound healing activity or/and may serve as a support for the release of bioactive compounds such as antimicrobial agents (antibiotics, antiseptics, honey, plant extracts), growth factors, insulin. Many dressings now exploit ‘bioactive’ properties to promote healing and control infection which includes sustained release of antimicrobial compounds. e.g. Actisorb Silver 220 and Acticoat. The use of alginates (e.g. Kaltostat, Tegagen, SorbSan, SeaSorb, Algisite M, Algosteril, Acticoat Absorbent, AGA-100), hydrocolloids, and materials containing collagen or other extracellular matrix components (hyaluronic acid) for maintaining a moist wound environment is increasing, as these dressings are believed to interact with cells or matrix proteins in the wound bed to promote healing. Promogran is used in the treatment of diabetic foot ulcers. Surgical grafting of split-thickness autologous skin using tissue-engineered ‘skin equivalents is the standard method for rapid closure of full-thickness burn wounds. Cell-free matrices are used to preserve the dermal architecture (e.g. Alloderm, Integra). Cell-containing matrices include both synthetic matrices, often made of polyglycolic acid mesh (e.g. Dermagraft), as well as natural biological substrates usually comprising collagen and glycosaminoglycans (e.g. Apligraf). Alternatively, non-cellular matrices, such as the hyaluronic acid scaffolds, (e.g. Hyalograft-3D, Laserskin – Hyaff-11) are recommended for culture with autologous patient cells prior to grafting.
The global bioactive wound dressings market segmentation is based on product types – antimicrobial dressings (chitosan-based, iodine-based, silver-based, chitin, honey), biological dressings (cell-based therapy, collagen dressings, keratin dressings, skin substitutes, growth factors, stem cell therapy), and moist dressings (alginate dressings, hydrocolloids dressings).
The global bioactive wound dressings market report provides market size (Revenue US$ Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global bioactive wound dressings market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global bioactive wound dressings market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global bioactive wound dressings market and profiled in this report include 3M Healthcare, Acelity (a KCI Company), B. Braun Melsungen AG, Cardinal Health, Coloplast A/S, ConvaTec, Cytori Therapeutics, Inc., Derma Sciences, Inc., Johnson and Johnson, Medtronic plc, Mölnlycke Health Care, Organogenesis, Inc., Paul Hartmann AG, and Smith & Nephew plc.